Detection of allergen exposure

US2021282702A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2021282702-A1
Application numberUS-202117333710-A
CountryUS
Kind codeA1
Filing dateMay 28, 2021
Priority dateDec 23, 2014
Publication dateSep 16, 2021
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

One example implementation includes an extractor controller to control extraction of blood from a user; a detection fluid manager to mix the blood and a detection fluid to form magnetized test particles, the detection fluid comprising dye coated magnetic particles; a particle flow controller to remove magnetized test particles from the mixed blood and detection fluid; and an allergen detector to detect exposure to an allergen based on a color of the test particles.

First claim

Opening claim text (preview).

1 - 15 . (canceled) 16 . An apparatus comprising: a detection fluid container containing detection fluid comprising dye coated magnetic particles, wherein the dye coated magnetic particles comprise a dye coating including histamine antibodies that change color when exposed to histamines and antibodies of the histamines; a particle flow controller comprising a magnet or an electromagnet that removes magnetic test particles from a mixing of blood extracted from a user with the detection fluid; a photodetector to determine a color of the dye coating based on a measurement of voltage of light reflecting from the magnetic test particles; an allergen detector system comprising a processor and memory storing executable stored instructions that, when executed, cause the processor to perform operations comprising: control a flow of the detection fluid from the detection fluid container to facilitate mixing of the blood extracted from the user and the detection fluid in a blood extraction pad to generate the magnetic test particles; and determine a color of the magnetic test particles based on the photodetector; and perform a blood analysis on the blood based on the color of the magnetic test particles, wherein the blood analysis determines a severity of an exposure to an allergen based on a threshold difference in the color of the magnetic test particles and a baseline measurement color due to the presence of histamines in the blood. 17 . The apparatus of claim 16 , further comprising: a light emitter, wherein the color of the magnetic test particles is determined further based on light emitted from the light emitter. 18 . The apparatus of claim 16 , further comprising: a blood extraction pad, wherein the mixing of the blood and the detection fluid occurs in the blood extraction pad. 19 . The apparatus of claim 16 , further comprising: a treatment provider comprising a drug container and a treatment cannula, wherein the allergen detector system notifies the treatment provider of an exposure to an allergen based on the blood analysis, causing the treatment provider to treat the user by injecting the user with a drug from the drug container via the treatment cannula. 20 . The apparatus of claim 16 , further comprising: a blood extractor comprising: a blood extraction pad, wherein the blood extracted from the user is received by the blood extraction pad; and an extraction cannula, wherein the blood extracted from the user is extracted by the extraction cannula. 21 . The apparatus of claim 16 , further comprising: a waste container, wherein the blood, the detection fluid, and the magnetized test particles are stored in the waste container after the blood analysis is performed. 22 . The apparatus of claim 16 , wherein the executable instructions further cause the processor to: perform a second blood analysis on second blood extracted from the user to confirm that an exposure to an allergen has occurred. 23 . The apparatus of claim 16 , wherein the color of the magnetic test particles are determined further based on a measurement of voltage. 24 . The apparatus of claim 16 , further comprising: a magnet; and a valve, wherein the magnetized test particles are moved toward a location of the allergen detector system based on the magnet and the valve. 25 . The apparatus of claim 16 , wherein the particle flow controller control the flow of magnetic test particles from the detection fluid to move toward a location of the allergen detector system.

Assignees

Inventors

Classifications

  • for computer-aided diagnosis, e.g. based on medical expert systems · CPC title

  • Immunology or allergic disorders · CPC title

  • A61B5/411Primary

    Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance · CPC title

  • Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms · CPC title

  • Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper {and including single- and multilayer analytical elements (immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2021282702A1 cover?
One example implementation includes an extractor controller to control extraction of blood from a user; a detection fluid manager to mix the blood and a detection fluid to form magnetized test particles, the detection fluid comprising dye coated magnetic particles; a particle flow controller to remove magnetized test particles from the mixed blood and detection fluid; and an allergen detector t…
Who is the assignee on this patent?
Hewlett Packard Entpr Dev Lp
What technology area does this patent fall under?
Primary CPC classification A61B5/411. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Sep 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).